January is Thyroid Awareness Month, and throughout the month, I'll be highlighting the various efforts, new content and information being disseminated as part of this international effort to raise thyroid awareness. 
About Mary Shomon | Thyroid Forum | Twitter | Facebook
Here are a few things to get you started:
American Association of Clinical Endocrinologists / Thyroid Awareness Month Site
Pharmacists Support Thyroid Awareness Month
Image: Mary Shomon
today the preliminary results of the Company’s ASAP (Anatabloc Supplementation Autoimmune Prevention) Human Thyroid Study that analyzes the impact of anatabine dietary supplementation on thyroid health.
(Logo: http://photos.prnewswire.com/prnh/20120301/NE62741LOGO )
The study is a three-month, five-visit, double-blind, placebo-controlled study of the impact of anatabine dietary supplementation in humans with autoimmune disease of the thyroid. The study was conducted at nine sites and builds upon previous epidemiological and animal experimental studies. Initial results for all study subjects suggest that dietary supplementation with anatabine ameliorates the immune system’s targeting of the thyroid gland in autoimmune thyroiditis.
Subjects in the study were screened initially to establish the presence of active autoimmune thyroid inflammation. Baseline thyroid sonography, thyroid antibody levels, and cytokine levels were collected from the subjects who were determined to have active autoimmune thyroid inflammation. Thyroid function tests and routine safety monitoring were also done in these subjects. Eligible subjects were enrolled in the study and then received weight-appropriate doses of anatabine or placebo, ranging from nine to twenty-four mg of the anatabine supplement or placebo per day. Subjects received treatment for three months, returning at four-week intervals for repeat laboratory testing
Read more: http://www.benzinga.com/news/earnings/13/01/3221979/star-scientific-reports-positive-initial-results-of-asap-human-thyroid-h#ixzz2HPk9608d